http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ee3157ee7b0747f905c290b3e1e45cd
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | A. Sharif Sharif |
| name | Najam A Sharif Najam A. Sharif |
| given-name | Najam A. Najam A Najam |
| organization-name | Pharmaceutical Products Research, Alcon Research, Ltd., Fort Worth, Texas. Santen Incorporated, Emeryville, California. Ophthalmology Discovery Research, Alcon Research, Ltd., Fort Worth, TX 76134, USA. naj.sharif@alconlabs.com Alcon Research, Ltd., Fort Worth, Texas. Department of Ophthalmology Novartis Institutes of Biomedical Research Institute Fort Worth TX 76134 USA Eye-APC Duke-National University of Singapore Medical School, Singapore.; Singapore Eye Research Institute, Singapore.; Department of Pharmacology and Neuroscience, University of North Texas Health Sciences Center, Fort Worth, Texas, USA.; Department of Pharmacy Sciences, Creighton University, Omaha, Nebraska, USA.; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, Texas, USA. Pharmaceutical Research, Alcon Research, Ltd., Fort Worth, TX, USA. naj.sharif@alcon.com Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, Texas. Molecular Pharmacology Unit, Alcon Research, Ltd, 6201 South Freeway, Fort Worth, Texas 76134 USA Pharmaceutical Products Research, Core Pharmacology & Imaging, Alcon Research Ltd., Fort Worth, TX 76134, USA. naj.sharif@alconlabs.com Global Alliances & External Research, Santen Incorporated, Emeryville, California.; Department of Pharmaceutical Sciences, Texas Southern University, Houston, Texas.; Department of Pharmacology and Neuroscience, University of North Texas Health Sciences Center, Fort Worth, Texas. Global Alliances and External Research, Ophthalmology Innovation Center, Santen Inc., Emeryville, California, USA.; Singapore Eye Research Institute (SERI), Singapore.; SingHealth Duke-NUS Ophthalmology and Visual Sciences Academic Clinical Programme, Duke-National University of Singapore Medical School, Singapore.; Department of Surgery and Cancer, Imperial College of Science and Technology, London, United Kingdom.; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, Texas, USA. Pharmaceutical Research Alcon Research, Ltd (A Novartis Company) Fort Worth TX USA Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia 23298-0540, Center for Neuropharmacology and Neuroscience, Albany Medical College, Albany, New York 12208, and Alcon Laboratories Inc., 6201 South Freeway, Fort Worth, Texas 76134-2099 From the Molecular Pharmacology Unit, Alcon Research, Ltd., Fort Worth, Texas; and the Alcon Research Laboratories, Ltd., Fort Worth, Texas. Ophthalmology Discovery Research, Alcon Research, Ltd., 6201 South Freeway, Fort Worth, Texas 76134, United States Ophthalmology Discovery Research, Alcon Research, Ltd., Fort Worth, TX. Department of Environmental and Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, Texas.; Santen Incorporated, Emeryville, California. Alcon Research Ltd., Fort Worth, Texas Molecular Pharmacology Unit (R2-19), Pharmaceutical Products, Alcon Research Ltd Department of Pharmacy Sciences, School of Pharmacy and Health Professions, Creighton University, Omaha, NE, and Molecular Pharmacology Unit Pharmaceutical Products, Alcon Research Ltd., Fort Worth, TX Pharmaceutical Research, Alcon Research, Ltd. (A Novartis Company), Fort Worth, Texas. Pharmaceutical Research, Alcon Research Ltd., Fort Worth, Texas. Molecular Pharmacology Unit, Pharmaceutical Products Research, Alcon Research, Ltd, Fort Worth, TX 76134-2099, USA Molecular Pharmacology Unit, Alcon Research, Ltd., Fort Worth, TX. Medicinal Chemistry, Molecular Pharmacology, and In Vivo Pharmacology Departments, Ophthalmic Products Research, Alcon Research, Ltd., 6201 South Freeway, Fort Worth, Texas 76134, and Department of Chemistry & Biochemistry, University of Texas, Austin, Texas 78712 Departments of Medicinal Chemistry and Molecular Pharmacology, Alcon Laboratories, Inc., 6201 South Freeway, MS R2-39, Ft. Worth, Texas 76134 Eye-APC Duke-NUS Medical School, Singapore 169856, Singapore; Singapore Eye Research Institute, Singapore 169856, Singapore; Department of Pharmacology and Neuroscience, University of North Texas Health Sciences Center, Fort Worth, TX 76107, USA; Department of Pharmacy Sciences, Creighton University, Omaha, NE 68178, USA; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX 77004, USA; Imperial College of Science and Technology, St. Mary’s Campus, London SW7 2BX, UK; Institute of Ophthalmology, University College London, London WC1E 6BT, UK Eye-APC Duke-NUS Medical School, Singapore 169857, Singapore; Singapore Eye Research Institute, Singapore 169856, Singapore; Department of Pharmacology and Neuroscience, University of North Texas Health Sciences Center, Fort Worth, TX 76107, USA; Department of Pharmacy Sciences, Creighton University, Omaha, NE 68178, USA; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX 77004, USA; Imperial College of Science and Technology, St. Mary’s Campus, London W2 1PG, UK; Institute of Ophthalmology, University College London, London WC1E 6BT, UK Ophthalmology Discovery Research, Alcon Research, Ltd., 6201 South Freeway, Fort Worth, Texas 76134 |
Incoming Links
Total number of triples: 130.